troglitazone has been researched along with tetradecanoylphorbol acetate in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 17 (70.83) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bähr, M; Bock, M; Eckel, J; Kiehn, R; Spelleken, M; von Holtey, M | 1 |
| Inoue, I; Katayama, S; Komoda, T; Miyazaki, T; Negishi, K; Sonoda, M; Takahashi, K | 1 |
| Libby, P; Marx, N; Murphy, C; Plutzky, J; Sukhova, G | 1 |
| Burris, TP; Demarest, KT; Pelton, PD; Zhou, L | 1 |
| Cannady, SB; Combs, CK; Johnson, DE; Karlo, JC; Landreth, GE | 1 |
| Bell, D; McDermott, BJ | 1 |
| Kitahara, M; Naitoh, T; Tsuruzoe, N | 1 |
| Chandraratna, RA; Fleck, E; Goetze, S; Graf, K; Hsueh, WA; Kim, S; Kintscher, U; Law, RE; Nagpal, S; Wakino, S | 1 |
| Eto, M; Hata, A; Horiuchi, S; Iwashima, Y; Kaku, K; Sano, H; Ushikubi, F | 1 |
| Harris, SG; Phipps, RP | 1 |
| Akuzawa, N; Kurabayashi, M; Nagai, R; Oyama, Y | 2 |
| Ando, K; Chiba, Y; Fujita, T; Ogita, T | 1 |
| Clyne, CD; Duong, JH; Gong, C; Murata, Y; Rubin, GL; Simpson, ER; Speed, CJ | 1 |
| Bierhaus, A; Brodbeck, K; Häring, HU; Schleicher, ED; Weigert, C | 1 |
| Hamaguchi, E; Nagai, Y; Shimizu, A; Takamura, T | 1 |
| Kannan, Y; Kinoshita, H; Moriyama, M; Nakamura, Y; Tokunaga, M | 1 |
| Hahn, JH; Kim, DJ; Kim, HA; Kim, PH; Lee, HS; Lee, KJ; Ma, KR; Park, JH | 1 |
| Fischer, SM; He, G; Lubet, RA; Muga, S; Thuillier, P | 1 |
| Li, F; Shi, J; Song, J; Wang, D; Zhou, Y | 1 |
| Eder, K; Ringseis, R; Saal, D; Schulz, N | 1 |
| Chowdhury, AA; Ishikawa, T; Jisaka, M; Nagaya, T; Nishimura, K; Rahman, MS; Shono, F; Yokota, K | 1 |
| Kato, K; Kim, KC; Lillehoj, EP; Park, CS; Park, YS | 1 |
| Chen, B; Chen, Y; Huang, Y; Li, J; Niu, Z; Shen, P; Tang, J; Zhang, W | 1 |
24 other study(ies) available for troglitazone and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Topics: 3-O-Methylglucose; Animals; Cells, Cultured; Chromans; Cytosol; Dose-Response Relationship, Drug; Glucose Transporter Type 1; Glucose Transporter Type 4; Heart Ventricles; Hypoglycemic Agents; Immune Sera; Immunoblotting; Isoenzymes; Lactic Acid; Male; Membrane Proteins; Monosaccharide Transport Proteins; Muscle Proteins; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone | 1996 |
Troglitazone has a scavenging effect on reactive oxygen species.
Topics: Antioxidants; Chromans; Cytochrome c Group; Dimethyl Sulfoxide; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Humans; Hydrogen Peroxide; Iron; Molecular Structure; Neutrophils; Pioglitazone; Reactive Oxygen Species; Spin Labels; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Troglitazone; Vitamin E; Xanthine; Xanthine Oxidase; Xanthines | 1997 |
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
Topics: Arteriosclerosis; Blotting, Northern; Blotting, Western; Cell Line; Cells, Cultured; Chromans; Collagenases; Humans; Immunoenzyme Techniques; Macrophages; Matrix Metalloproteinase 9; Monocytes; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1998 |
PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.
Topics: Adipocytes; Carrier Proteins; Cell Differentiation; Cell Line; Cells, Cultured; Chromans; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression; Humans; Kinetics; Monocytes; Myelin P2 Protein; Neoplasm Proteins; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Suppressor Proteins | 1999 |
Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Brain; Cell Differentiation; Chromans; Cyclooxygenase 2; Dinoprost; Genes, Reporter; Humans; Inflammation; Interleukin-6; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred C57BL; Microbodies; Microglia; Monocytes; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Troglitazone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum.
Topics: Animals; Cattle; Cell Differentiation; Cell Survival; Chromans; Culture Media; Dose-Response Relationship, Drug; Drug Interactions; Endothelin-1; Fetal Blood; Glucose; Heart Ventricles; Hydrogen-Ion Concentration; Hypertrophy; Hypoglycemic Agents; Insulin; Insulin-Like Growth Factor I; Male; Myocardium; Norepinephrine; Phenylalanine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
Topics: Antineoplastic Agents; Carcinogens; Cell Survival; Cells, Cultured; Chromans; Humans; Hypoglycemic Agents; Ligands; Monocytes; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha | 2000 |
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Cell Movement; Chemokine CCL2; Chemotaxis; Chromans; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinases; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2000 |
Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.
Topics: Blotting, Northern; CD36 Antigens; Cell Line; Cells, Cultured; Chromans; DNA, Complementary; Dose-Response Relationship, Drug; Flow Cytometry; Foam Cells; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Immunohistochemistry; Macrophages; Membrane Proteins; Microscopy, Fluorescence; Monocytes; NF-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, LDL; Receptors, Lipoprotein; Receptors, Oxidized LDL; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scavenger Receptors, Class A; Scavenger Receptors, Class B; Scavenger Receptors, Class E; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Troglitazone; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Up-Regulation | 2000 |
The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis.
Topics: Animals; Antigen Presentation; Apoptosis; Cell Division; Cell Survival; Cells, Cultured; Chromans; Flow Cytometry; Immunohistochemistry; In Situ Nick-End Labeling; Ionomycin; Ligands; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Transgenic; Prostaglandin D2; Pyrimidines; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Specific Pathogen-Free Organisms; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Troglitazone, a PPARgamma ligand, inhibits osteopontin gene expression in human monocytes/macrophage THP-1 cells.
Topics: Base Sequence; Cell Differentiation; Cells, Cultured; Chromans; Gene Expression Regulation; Humans; Ligands; Luciferases; Macrophages; Molecular Sequence Data; Monocytes; Osteopontin; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Sialoglycoproteins; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2000 |
PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.
Topics: Animals; Arteriosclerosis; Cattle; Cells, Cultured; Chromans; Drug Antagonism; Endothelium; Immunohistochemistry; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Oxidized LDL; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone; Tumor Necrosis Factor-alpha | 2001 |
PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells.
Topics: Animals; AT Rich Sequence; Cell Line; Chromans; COS Cells; Gene Expression; Gene Expression Regulation; Genes, Reporter; Humans; Hypoglycemic Agents; Ligands; Monocytes; Mutagenesis, Site-Directed; Nuclear Proteins; Osteopontin; Promoter Regions, Genetic; Protein Binding; Rabbits; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Sialoglycoproteins; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Troglitazone | 2002 |
Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Topics: Adipose Tissue; Aromatase; Base Sequence; Chromans; Colforsin; Female; Gene Expression Regulation, Enzymologic; Humans; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Tetradecanoylphorbol Acetate; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones.
Topics: Animals; Cells, Cultured; Chromans; Glucose; Hydrogen Peroxide; Mice; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Swine; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Troglitazone | 2003 |
Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Topics: Blotting, Northern; Cell Line; Cell Survival; Cells, Cultured; Chromans; Endothelial Cells; Humans; Hypoglycemic Agents; Interleukin-1; Mitogen-Activated Protein Kinases; NF-kappa B; Plasminogen Activator Inhibitor 1; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha; Umbilical Veins | 2003 |
Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice.
Topics: Animals; Ascitic Fluid; Blood Glucose; Cells, Cultured; Chemotaxis, Leukocyte; Chromans; Cytokines; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Neutrophil Infiltration; Neutrophils; Phagocytosis; Superoxides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Zymosan | 2004 |
Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g.
Topics: Antibodies, Blocking; CD36 Antigens; Cells, Cultured; Chromans; Humans; Lipoproteins, LDL; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Monocytes; NF-kappa B; PPAR gamma; Prostaglandin D2; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription, Genetic; Troglitazone | 2004 |
The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Chromans; Diet; Female; Keratinocytes; Ligands; Mice; PPAR gamma; RNA, Messenger; Rosiglitazone; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Ultraviolet Rays | 2005 |
Different roles of protein kinase C-betaI and -delta in the regulation of adipocyte differentiation.
Topics: 3T3-L1 Cells; Acetophenones; Adipocytes; Adipogenesis; Animals; Benzopyrans; Carbazoles; Cell Differentiation; Cell Membrane; Cell Proliferation; Chromans; Cytosol; Epidermal Growth Factor; Gene Expression; Genes, Dominant; Indoles; Mice; Mutant Proteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Protein Transport; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
Topics: Cell Survival; Cells, Cultured; Chromans; Gene Expression; Humans; Linoleic Acids, Conjugated; Lipid Metabolism; Macrophages; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NF-kappa B; PPAR gamma; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Troglitazone | 2008 |
15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Arachidonic Acid; Calcimycin; Cell Proliferation; Chromans; Dinoprost; Dinoprostone; Gene Expression; Ionophores; Isoenzymes; Lipid Metabolism; Mice; NF-kappa B; PPAR gamma; Proline; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Tetradecanoylphorbol Acetate; Thiazolidinediones; Thiocarbamates; Triglycerides; Troglitazone | 2011 |
PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism.
Topics: Animals; Cell Line; Chromans; Epithelial Cells; Humans; Interleukin-8; Lung; Male; Mice; Mucin-1; Mucous Membrane; PPAR gamma; Promoter Regions, Genetic; Pseudomonas aeruginosa; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha | 2012 |
Caspase-1 promotes monocyte-macrophage differentiation by repressing PPARγ.
Topics: Binding Sites; Caspase 1; Cell Differentiation; Chromans; Gene Expression Regulation; Humans; Hypoglycemic Agents; Leukemia, Monocytic, Acute; Macrophages; Monocytes; NF-kappa B; PPAR gamma; Primary Cell Culture; Protein Binding; Signal Transduction; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone | 2017 |